Suppr超能文献

希腊克里特岛儿童尿路病原体的抗菌药物耐药性

Antimicrobial resistance of urinary tract pathogens in children in Crete, Greece.

作者信息

Anatoliotaki Maria, Galanakis Emmanouil, Schinaki Athina, Stefanaki Sofia, Mavrokosta Maria, Tsilimigaki Amalia

机构信息

Department of Paediatrics, Venizelion General Hospital, Heraklion, Crete, Greece.

出版信息

Scand J Infect Dis. 2007;39(8):671-5. doi: 10.1080/00365540701199899.

Abstract

The aim of the present study was to identify the organisms responsible for community acquired febrile UTI in children and to investigate their susceptibility to commonly used antibiotics. A 5-y prospective analysis was performed in children hospitalized for a first episode of UTI, in Crete, Greece. A total of 262 children, 40.1% males and 59.9% females, aged 0.08 to 13 y, were enrolled in the study. Escherichia coli (E. coli) was the leading uropathogen. Antimicrobial resistance of E. coli isolates was most commonly to ampicillin (56.4%) followed by trimethoprim-sulfamethoxazole (TMP-SMX) (27.3%), cefaclor (22.5%), amoxicillin-clavulanate (15.5%), gentamicin (4.9%), cefuroxime (3.1%), nitrofurantoin (2.6%), and ceftriaxone (1.6%). Interestingly, a significant decrease in E. coli resistance to TMP-SMX was observed during the study period. Resistance to ampicillin, TMP-SMX and cefaclor was noted for 61%, 28% and 27% of the total uropathogens, respectively, making these agents inappropriate for empirical treatment of febrile UTI in our region. A larger number of pathogens may be empirically treated with amoxicillin-clavulanate. More than 90% of the uropathogens are susceptible to cefuroxime, ceftriaxone, gentamicin, and nitrofurantoin. In conclusion, several of the first-line agents for empirical treatment of childhood UTI seem to have become ineffective in the area of this study.

摘要

本研究的目的是确定导致儿童社区获得性发热性尿路感染的病原体,并调查它们对常用抗生素的敏感性。在希腊克里特岛,对因首次尿路感染住院的儿童进行了为期5年的前瞻性分析。共有262名儿童参与了该研究,年龄在0.08至13岁之间,其中男性占40.1%,女性占59.9%。大肠埃希菌(大肠杆菌)是主要的尿路病原体。大肠杆菌分离株的耐药性最常见于氨苄西林(56.4%),其次是甲氧苄啶-磺胺甲恶唑(TMP-SMX)(27.3%)、头孢克洛(22.5%)、阿莫西林-克拉维酸(15.5%)、庆大霉素(4.9%)、头孢呋辛(3.1%)、呋喃妥因(2.6%)和头孢曲松(1.6%)。有趣的是,在研究期间观察到大肠杆菌对TMP-SMX的耐药性显著下降。分别有61%、28%和27%的尿路病原体对氨苄西林、TMP-SMX和头孢克洛耐药,这使得这些药物不适用于我们地区发热性尿路感染的经验性治疗。更多的病原体可以用阿莫西林-克拉维酸进行经验性治疗。超过90%的尿路病原体对头孢呋辛、头孢曲松、庆大霉素和呋喃妥因敏感。总之,在本研究区域,几种用于儿童尿路感染经验性治疗的一线药物似乎已经失效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验